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Complications of cardiac resynchronization
therapy (CRT) are not infrequent and include high
pacing thresholds, lead micro-dislodgement and
phrenic nerve stimulation, all of which may neces-
sitate coronary sinus (CS) lead repositioning [1].
The technology from the manufacturers of these
devices is evolving in a bid to reduce the need for
repeated surgery, which is recognized to be asso-
ciated with increased morbidity and mortality [2].
St Jude Medical has developed a new quadri-
polar lead designed to be placed in a branch of the
coronary sinus (Quartet® Model 1458Q, Sylmar, CA,
USA) with the ability to pace from a distal electrode
(D1) and from three additional poles (M2, M3, P4)
allowing up to 10 different pacing configurations.
The properties of this quadripolar lead allow the
operator to pace the left ventricle at different loca-
tions within the branch of the CS using different
pacing configurations with the aim of significantly
increasing the possibility of obtaining a low pacing
threshold and simultaneously reducing the likeli-
hood of phrenic nerve stimulation.
In a recent study assessing the use of this quad-
ripolar lead, 71 out of 75 patients underwent suc-
cessful implantation of this lead [3]. The ability to
identify a suitable pacing site within a branch of the
CS increased from 86% (with a traditional true bi-
polar configuration) to 97% using 2 or more alter-
nate configurations. The reduction of phrenic nerve
stimulation using the Quartet® lead has also been
evaluated separately by Mehta et al. [4]. They re-
ported a reduction not only in phrenic nerve stimu-
lation at the time of implantation, but were able to
overcome this problem in 5 patients that subse-
quently developed this complication during follow-
-up by changing to a different pacing configuration,
thereby avoiding the need for further surgical in-
tervention.
In a further study by Forleo et al. [5], a com-
parison between quadripolar and bipolar leads in
45 patients demonstrated a significant reduction in
phrenic nerve stimulation during the first 3 months
following implantation in the group receiving the
quadripolar lead.
In this volume of Cardiology Journal, Arias et al.
[6] describe their experience in prospectively com-
paring 21 patients receiving the Quartet® lead with
21 patients receiving a conventional bipolar lead and
provide the longest follow-up available to date
(9 months). In keeping with previous studies, implan-
tation of the lead was successful in all patients. Of
note, in the group receiving the conventional bipo-
lar lead, the likelihood of using more than one lead
was significantly higher (p = 0.04) and the procedure
associated with longer fluoroscopy times (p = 0.03).
In addition, in the present study, phrenic nerve stim-
ulation was seen more frequently in the group re-
ceiving the bipolar lead with surgical re-intervention
required in 1 case. In contrast, no patients in the
group receiving the quadripolar lead required surgi-
cal intervention to correct phrenic nerve stimulation.
The results of this study extend previous find-
ings, although as recognized by the authors, comes
with the caveat that it lacks randomization which may
have therefore introduced a possible selection bias.
A simple, reliable means of delivering a CS lead
with good pacing thresholds and avoiding phrenic
stimulation remains the Holy Grail for CRT implan-
tation. Arias et al. [6] have contributed to this
search, demonstrating that the use of the Quartet®
quadripolar lead adds to the armamentarium avail-
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able to the operator. Although our search for the
Holy Grail continues, we may be inching closer.
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